Chinese medicine cold drugs in many places in China are popular, and the stock out of stock in some areas is also working overtime.Some investors expect that the price of raw materials in the upstream Chinese medicinal materials may increase significantly.

According to the report of the Caizhong News Agency on November 25, the reporter visited the pharmacy in many places on the spot that due to the reduction of frequency of influenza in temperature and the demand for epidemic prevention, the sales of colds and epidemic prevention drugs have risen recently.Some pharmacy staff revealed that even the flowers of flowers Qing Plague, Huoxiang Zhengqi, Cold Spiritual Granules, Banlangen, and Children's Cold Medicine have a large demand in the near future.

Terminal demand has increased, and some pharmaceutical companies have also stepped up the opportunity to greatly improve their production capacity.Traditional Chinese medicine manufacturers such as Ling Pharmaceutical and Sunflower Pharmaceuticals have expanded short -term people and quickly produce medicines such as colds and diseases.In addition, Tailong Pharmaceutical and other pharmaceutical companies produce first -tier employees in the factory to ensure safety production.

Due to the increase in the output of downstream pharmaceutical plants, some Chinese medicinal materials have risen in some Chinese medicinal materials.The staff of the Chinese medicinal materials distribution bases such as Bozhou, Anguo, Gansu, etc. revealed that recently, the amount of cough and phlegm drugs such as Chaihu, licorice, etc. have increased significantly, and the prices of some medicinal materials of some heat -clearing and detoxifying medicinal materials have risen.In the past one or two weeks, the forsythia clear heat and detoxification medicinal materials have risen by about 10%, and the increase is not too large. The increase in Banlangen, Pselives, and Coptis chinensis is also within 20%.

However, due to the increase in yield, more market inventory, sufficient stocking of large pharmaceutical factories, and self -built medicinal materials bases, people in the industry believe that most of the medicinal materials have not yet met.The subsequent changes in prices still need to pay attention to market demand.